Amoxicillin Pulsys fails second Phase III

Advancis (AVNC) and Par (PRX) said Amoxicillin Pulsys missed the primary endpoint in a pediatric Phase III trial to treat pharyngitis/tonsillitis due to Group A streptococcal infections. The primary e...